WEBULL
News
NRXBF
0.489
NaN%
--
Weekly Report: what happened at NRXBF last week (1222-1226)?
Weekly Report · 12/29/2025 10:29
Weekly Report: what happened at NRXBF last week (1215-1219)?
Weekly Report · 12/22/2025 10:29
NUREXONE BIOLOGIC INC - ANNOUNCES EXOSOMES REDUCE INFLAMMATORY ACTIVITY
Reuters · 12/19/2025 21:05
NurExone Reports Anti-Inflammatory Activity of Its Exosomes in Lab Analysis
Barchart · 12/19/2025 15:04
Weekly Report: what happened at NRXBF last week (1208-1212)?
Weekly Report · 12/15/2025 10:38
NurExone Plans Small-Scale of ExoPTEN Clinical Manufacturing in Preparation for FUTURE First in Human USE Pathways
Barchart · 12/12/2025 15:04
Weekly Report: what happened at NRXBF last week (1201-1205)?
Weekly Report · 12/08/2025 10:36
Weekly Report: what happened at NRXBF last week (1124-1128)?
Weekly Report · 12/01/2025 10:31
Biotechnology firm NurExone's Q3 net loss widens
Reuters · 11/28/2025 14:26
NurExone Biologic Inc. Announces Third Quarter 2025 Financial Results and Provides Corporate Update
Barchart · 11/28/2025 08:15
Weekly Report: what happened at NRXBF last week (1117-1121)?
Weekly Report · 11/24/2025 10:36
NurExone Biologic Inc. Plans to Advance ExoPTEN and Therapeutic Pipeline Toward Clinical Readiness, Allocate New Funding to Clinical Development and Key Operational Priorities
Reuters · 11/17/2025 14:24
Weekly Report: what happened at NRXBF last week (1110-1114)?
Weekly Report · 11/17/2025 10:37
NurExone secures over C$3.18M through warrant exercise
Seeking Alpha · 11/12/2025 21:26
Weekly Report: what happened at NRXBF last week (1103-1107)?
Weekly Report · 11/10/2025 10:34
Weekly Report: what happened at NRXBF last week (1027-1031)?
Weekly Report · 11/03/2025 10:34
Weekly Report: what happened at NRXBF last week (1020-1024)?
Weekly Report · 10/27/2025 10:39
Weekly Report: what happened at NRXBF last week (1013-1017)?
Weekly Report · 10/20/2025 10:34
Weekly Report: what happened at NRXBF last week (1006-1010)?
Weekly Report · 10/13/2025 10:37
Weekly Report: what happened at NRXBF last week (0929-1003)?
Weekly Report · 10/06/2025 10:33
More
Webull provides a variety of real-time NRXBF stock news. You can receive the latest news about Nurexone Biologic Inc through multiple platforms. This information may help you make smarter investment decisions.
About NRXBF
Nurexone Biologic Inc is an Israel-based company engaged primarily in the pharmaceutical sector. The Company is engaged in developing a platform for biologically guided exosome-based therapies to be delivered, minimally invasive, to patients who have suffered central nervous system injuries. The Company’s flagship product, ExoPTEN for acute spinal cord injury, uses exosomes loaded with a specific and sIRNA sequence as the active pharmaceutical ingredient. Its ExoTherapy is a platform for developing exosome-based therapies. The NurExone platform technology is expected to offer solutions to drug companies interested in minimally invasive targeted drug delivery for other indications. The Company focuses on research and development of pharmaceutical technologies.